APA (7th ed.) Citation

Hux, M., Zou, D., Ma, E., Sajosi, P., Engstrom, A., Selby, R., . . . Bonthapally, V. A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Hux, Margaret, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, and Vijayveer Bonthapally. A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Hux, Margaret, et al. A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma. Columbia Data Analytics, LLC.